Who backs Enlaza Therapeutics?
13 investors| Investor | Type |
|---|---|
| Lightspeed Venture Partners | Venture capital |
| Alexandria Venture Investments | Other |
| Samsara BioCapital | Venture capital |
| Pfizer Ventures | Other |
| Frazier Healthcare Partners | Venture capital |
| JP Morgan Asset Management | Asset manager |
| Amgen Ventures | — |
| Avalon Bioventures | — |
| Avalon Ventures | — |
| Bregua Corporation | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Enlaza Therapeutics investors
13 investors are on record for Enlaza Therapeutics, including Lightspeed Venture Partners, Alexandria Venture Investments, Samsara BioCapital and Pfizer Ventures. The early-stage round in Aug 2025 drew 1 investor.
Free account
More of Enlaza Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Enlaza Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Enlaza Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View